Gene Therapy Trial Patients, in Death, Helping Show What Did and Didn’t Work
Delivering a gene therapy directly to the substantia nigra, an area of the brain affected by …
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Delivering a gene therapy directly to the substantia nigra, an area of the brain affected by …
An important signaling pathway that helps protect brain cells from neurodegenerative diseases such as Parkinson’s…
Placing electrodes directly in the brains of people with Parkinson’s disease revealed a…
More than one-third of older people with Parkinson’s disease in long-term care who…
A blood test may be able to predict early cognitive decline in people with Parkinson’s disease by…
A new potential target for treating Parkinson’s, a protein named Drp1, has been identified using a rat…
People with Parkinson’s disease reported a need for increased planning in their lives due to limited mobility and…
Palliative care — focusing on physical, psychosocial and spiritual treatment — for people with Parkinson’s disease and…
Two Louisiana Tech University biomedical engineering students designed a wearable medical device that can track and classify…
Elevated blood levels of the liver enzyme gamma-glutamyltransferase (GGT), a marker for liver disease, was found to…
Get regular updates to your inbox.